PT Darya-Varia Laboratoria Tbk (IDX: DVLA)
Indonesia
· Delayed Price · Currency is IDR
1,635.00
0.00 (0.00%)
Nov 22, 2024, 3:25 PM WIB
DVLA Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 2,134,031 | 1,890,888 | 1,917,041 | 1,900,894 | 1,829,700 | 1,813,020 | Upgrade
|
Revenue Growth (YoY) | 22.70% | -1.36% | 0.85% | 3.89% | 0.92% | 6.67% | Upgrade
|
Cost of Revenue | 1,009,196 | 915,648 | 910,918 | 905,125 | 899,141 | 841,589 | Upgrade
|
Gross Profit | 1,124,835 | 975,240 | 1,006,123 | 995,768 | 930,558 | 971,432 | Upgrade
|
Selling, General & Admin | 861,683 | 797,516 | 830,427 | 806,071 | 726,548 | 678,004 | Upgrade
|
Other Operating Expenses | 14,887 | -8,463 | -14,269 | -5,722 | -4,493 | -10,668 | Upgrade
|
Operating Expenses | 876,570 | 789,053 | 816,158 | 800,349 | 722,055 | 667,336 | Upgrade
|
Operating Income | 248,265 | 186,186 | 189,966 | 195,419 | 208,503 | 304,096 | Upgrade
|
Interest Expense | -55.66 | -68.28 | -171.15 | -123.47 | -78.59 | - | Upgrade
|
Interest & Investment Income | 3,109 | 2,071 | 3,621 | 4,144 | 4,290 | 5,783 | Upgrade
|
Currency Exchange Gain (Loss) | 1,261 | - | 6,427 | 10,892 | 1,855 | -8,844 | Upgrade
|
EBT Excluding Unusual Items | 252,579 | 188,189 | 199,843 | 210,332 | 214,570 | 301,035 | Upgrade
|
Gain (Loss) on Sale of Assets | 4,908 | 3,450 | 1,230 | 1,179 | -500.45 | 215.13 | Upgrade
|
Pretax Income | 257,487 | 191,638 | 201,073 | 211,511 | 214,069 | 301,250 | Upgrade
|
Income Tax Expense | 63,581 | 45,302 | 51,698 | 65,006 | 51,996 | 79,467 | Upgrade
|
Net Income | 193,905 | 146,336 | 149,375 | 146,505 | 162,073 | 221,783 | Upgrade
|
Net Income to Common | 193,905 | 146,336 | 149,375 | 146,505 | 162,073 | 221,783 | Upgrade
|
Net Income Growth | 131.11% | -2.03% | 1.96% | -9.61% | -26.92% | 10.53% | Upgrade
|
Shares Outstanding (Basic) | 1,120 | 1,120 | 1,120 | 1,120 | 1,120 | 1,119 | Upgrade
|
Shares Outstanding (Diluted) | 1,120 | 1,120 | 1,120 | 1,120 | 1,120 | 1,119 | Upgrade
|
Shares Change (YoY) | - | - | - | - | 0.11% | 0.25% | Upgrade
|
EPS (Basic) | 173.13 | 130.66 | 133.37 | 130.81 | 144.71 | 198.24 | Upgrade
|
EPS (Diluted) | 173.13 | 130.66 | 133.37 | 130.81 | 144.71 | 198.24 | Upgrade
|
EPS Growth | 131.11% | -2.03% | 1.96% | -9.61% | -27.00% | 10.25% | Upgrade
|
Free Cash Flow | 207,867 | 11,270 | -74,245 | 350,220 | 43,777 | 213,583 | Upgrade
|
Free Cash Flow Per Share | 185.60 | 10.06 | -66.29 | 312.70 | 39.09 | 190.91 | Upgrade
|
Dividend Per Share | 108.000 | 108.000 | 119.000 | 114.000 | 110.000 | 107.000 | Upgrade
|
Dividend Growth | -10.74% | -9.24% | 4.39% | 3.64% | 2.80% | 0% | Upgrade
|
Gross Margin | 52.71% | 51.58% | 52.48% | 52.38% | 50.86% | 53.58% | Upgrade
|
Operating Margin | 11.63% | 9.85% | 9.91% | 10.28% | 11.40% | 16.77% | Upgrade
|
Profit Margin | 9.09% | 7.74% | 7.79% | 7.71% | 8.86% | 12.23% | Upgrade
|
Free Cash Flow Margin | 9.74% | 0.60% | -3.87% | 18.42% | 2.39% | 11.78% | Upgrade
|
EBITDA | 307,788 | 247,360 | 248,677 | 251,138 | 264,612 | 358,027 | Upgrade
|
EBITDA Margin | 14.42% | 13.08% | 12.97% | 13.21% | 14.46% | 19.75% | Upgrade
|
D&A For EBITDA | 59,523 | 61,174 | 58,712 | 55,719 | 56,109 | 53,931 | Upgrade
|
EBIT | 248,265 | 186,186 | 189,966 | 195,419 | 208,503 | 304,096 | Upgrade
|
EBIT Margin | 11.63% | 9.85% | 9.91% | 10.28% | 11.40% | 16.77% | Upgrade
|
Effective Tax Rate | 24.69% | 23.64% | 25.71% | 30.73% | 24.29% | 26.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.